GENFIT Pipeline Day Highlights Diverse Product Portfolio in

Phase 3 data for elafibranor in primary biliary cholangitis (PBC) expected in 2Q23Expanded pipeline now covers five therapeutic areas with high unmet...

Related Keywords

Germany , United States , Massachusetts , Madrid , Spain , California , France , Switzerland , Jenniferc Lai , Pascal Prigent , John Hopkins , Angela Lamarca , Mark Yarchoan , Jonel Trebicka , Genoscience Pharma , Department Of Internal Medicine , University Of California , Drug Administration , Nasdaq , Fundacion Jimenez Diaz University Hospital , Pipeline Program , Euronext , Pipeline Day , New York , Chief Executive Officer , Expert Speakers , Transplant Hepatologist , Internal Medicine , Associate Professor , Medical Oncology , Bay Life Science Advisors , Key Opinion Leaders , Child Pugh Score , Orphan Drug Designation , Paris Stock Exchange Gnft , Genfit Sa ,